Thrombotic outcomes in patients in a large clinical enterprise following COVID-19 vaccination

Vaccination against COVID-19 reduces infection-related mortality. Unfortunately, reports of vaccine-induced immune thrombotic thrombocytopenia (VITT) in individuals administered adenovirus-vector-based vaccines (ChAdOx1 nCoV-19 and Ad26.COV2.S) have spurred side effect concerns. To address vaccine h...

Descripción completa

Detalles Bibliográficos
Autores principales: Patterson, William M., Greene, Brady D., Tefera, Leben, Bena, James, Milinovich, Alex, Mehta, Neil, Chung, Mina K., Kapadia, Samir, Svensson, Lars G, Cameron, Scott J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848706/
https://www.ncbi.nlm.nih.gov/pubmed/36653575
http://dx.doi.org/10.1007/s11239-022-02764-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848706/
https://www.ncbi.nlm.nih.gov/pubmed/36653575
http://dx.doi.org/10.1007/s11239-022-02764-9

Ejemplares similares